Lilly's COVID-19 drug reduces death risk in patients on ventilator
August 03, 2021 at 10:12 AM EDT
Eli Lilly and Co. said new data from a Phase 3 trial showed its COVID-19 drug, baricitinib, was shown to reduce deaths in patients receiving mechanical ventilation.
